Prostaglandin D2 receptors control osteoclastogenesis and the activity of human osteoclasts

Journal of Bone and Mineral Research

Volumn 23, Issue 7, 2008, Pages 1097-1105

  Durand, Marianne ^a   Gallant, Maxime A ^a   De Brum Fernandes, Artur J ^a,b  

^a Centre Hospitalier Universitaire de Sherbrooke   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Bone resorption; Cytoskeleton; Osteoclastogenesis; Osteoclasts; Prostaglandin D2

Indexed keywords

ACTIN; COLONY STIMULATING FACTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROSTAGLANDIN D2; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ARTICLE; BONE TISSUE; CELL DIFFERENTIATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOSKELETON; FETUS; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LAMELLIPODIUM; OSTEOARTHRITIS; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PAGET BONE DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; CELL DIVISION; CYTOLOGY; METABOLISM; PHYSIOLOGY;

CELL DIFFERENTIATION; CELL DIVISION; HUMANS; OSTEOCLASTS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN;

EID: 46249090619     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.080228     Document Type: Article

References (40)

1. Ueno R, Honda K, Inoue S, Hayaishi O 1983 Prostaglandin D2, a cerebral sleep-inducing substance in rats. Proc Natl Acad Sci USA 80:1735-1737.
2. Hardy CC, Robinson C, Tattersfield AE, Holgate ST 1984 The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med 311:209-213.
3. Ito S, Narumiya S, Hayaishi O 1989 Prostaglandin D2: A biochemical perspective. Prostaglandins Leukot Essent Fatty Acids 37:219-234.
4. Yamaguchi DT, Green J, Merritt BS, Kleeman CR, Muallem S 1989 Modulation of osteoblast function by prostaglandins. Am J Physiol 257:F755-F761.
5. Koshihara Y, Kawamura M 1989 Prostaglandin D2 stimulates calcification of human osteoblastic cells. Biochem Biophys Res Commun 159:1206-1212.
6. Tokuda H, Kozawa O, Harada A, Uematsu T 1999 Prostaglandin D2 induces interleukin-6 synthesis via Ca2+ mobilization in osteoblasts: Regulation by protein kinase C. Prostaglandins Leukot Essent Fatty Acids 61:189-194.
7. Kozawa O, Otsuka T, Hatakeyama D, Niwa M, Matsuno H, Ito H, Kato K, Matsui N, Uematsu T 2001 Mechanism of prostaglandin D(2)-stimulated heat shock protein 27 induction in osteoblasts. Cell Signal 13:535-541.
8. Takagi T, Yamamoto T, Asano S, Tamaki H 1993 Effect of prostaglandin D2 on the femoral bone mineral density in ovariectomized rats. Calcif Tissue Int 52:442-446.
9. Boie Y, Sawyer N, Slipetz DM, Metters KM, Abramovitz M 1995 Molecular cloning and characterization of the human prostanoid DP receptor. J Biol Chem 270:18910-18916.
10. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, Nagata K 2001 Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193:255-261.
11. Gallant MA, Samadfam R, Hackett JA, Antoniou J, Parent JL, de Brum-Fernandes AJ 2005 Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors. J Bone Miner Res 20:672-681.
12. Hackett JA, Allard-Chamard H, Sarrazin P, de Fatima Lucena M, Gallant MA, Fortier I, Nader M, Parent JL, Bkaily G, de Brum-Fernandes AJ 2006 Prostaglandin production by human osteoclasts in culture. J Rheumatol 33:1320-1328.
13. Sarrazin P, Hackett JA, Fortier I, Gallant MA, de Brum-Fernandes A 2004 Role of EP3 and EP4 prostaglandin receptors in reorganization of the cytoskeleton in mature human osteoclasts. J Rheumatol 31:1598-1606.
14. Fortier I, Gallant MA, Hackett JA, Patry C, de Brum-Fernandes AJ 2004 Immunolocalization of the prostaglandin E2 receptor subtypes in human bone tissue: Differences in foetal, adult normal, osteoporotic and pagetic bone. Prostaglandins Leukot Essent Fatty Acids 70:431-439.
15. Itonaga I, Sabokbar A, Neale SD, Athanasou NA 1999 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. Biochem Biophys Res Commun 264:590-595.
16. Kozawa O, Tokuda H, Suzuki A, Kotoyori J, Ito Y, Oiso Y 1994 Effect of glucocorticoid on prostaglandin F2 alpha-induced prostaglandin E2 synthesis in osteoblast-like cells: Inhibition of phosphoinositide hydrolysis by phospholipase C as well as phospholipase A2. Eur J Endocrinol 131:510-515.
17. de Brum-Fernandes AJ, Laporte S, Heroux M, Lora M, Patry C, Menard HA, Dumais R, Leduc R 1994 Expression of prostaglandin endoperoxide synthase-1 and prostaglandin endoperoxide synthase-2 in human osteoblasts. Biochem Biophys Res Commun 198:955-960.
18. Ishizuka T, Matsui T, Okamoto Y, Ohta A, Shichijo M 2004 Ramatroban (BAY u 3405): A novel dual antagonist of TXA2 receptor and CRTh2, a newly identified prostaglandin D2 receptor. Cardiovasc Drug Rev 22:71-90.
19. Jurdic P, Saltel F, Chabadel A, Destaing O 2006 Podosome and sealing zone: Specificity of the osteoclast model. Eur J Cell Biol 85:195-202.
20. Marchisio PC, Cirillo D, Naldini L, Primavera MV, Teti A, Zambonin-Zallone A 1984 Cell-substratum interaction of cultured avian osteoclasts is mediated by specific adhesion structures. J Cell Biol 99:1696-1705.
21. Lakkakorpi PT, Vaananen HK 1991 Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro. J Bone Miner Res 6:817-826.
22. Teti A, Marchisio PC, Zallone AZ 1991 Clear zone in osteoclast function: Role of podosomes in regulation of bone-resorbing activity. Am J Physiol 261:C1-C7.
23. Murad F, Brewer HB Jr, Vaughan M 1970 Effect of thyrocalcitonin on adenosine 3′:5′-cyclic phosphate formation by rat kidney and bone. Proc Natl Acad Sci USA 65:446-453.
24. Marx SJ, Woodward CJ, Aurbach GD 1972 Calcitonin receptors of kidney and bone. Science 178:999-1001.
25. Monneret G, Gravel S, Diamond M, Rokach J, Powell WS 2001 Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 98:1942-1948.
26. Kajiya H, Okamoto F, Fukushima H, Takada K, Okabe K 2003 Mechanism and role of high-potassium-induced reduction of intracellular Ca2+ concentration in rat osteoclasts. Am J Physiol Cell Physiol 285:C457-C466.
27. Kobayashi Y, Take I, Yamashita T, Mizoguchi T, Ninomiya T, Hattori T, Kurihara S, Ozawa H, Udagawa N, Takahashi N 2005 Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors. J Biol Chem 280:24035-24042.
28. Collins DA, Chambers TJ 1991 Effect of prostaglandins E1, E2, and F2 alpha on osteoclast formation in mouse bone marrow cultures. J Bone Miner Res 6:157-164.
29. Okada Y, Pilbeam C, Raisz L, Tanaka Y 2003 Role of cyclooxygenase-2 in bone resorption. J UOEH 25:185-195.
30. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Goto M, Mochizuki SI, Tsuda E, Morinaga T, Udagawa N, Takahashi N, Suda T, Higashio K 1999 A novel molecular mechanism modulating osteoclast differentiation and function. Bone 25:109-113.
31. Nagai M, Sato N 1999 Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. Biochem Biophys Res Commun 257:719-723.
32. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T 1999 Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: Receptor activator of NF-kappa B ligand. Bone 25:517-523.
33. Take I, Kobayashi Y, Yamamoto Y, Tsuboi H, Ochi T, Uematsu S, Okafuji N, Kurihara S, Udagawa N, Takahashi N 2005 Prostaglandin E2 strongly inhibits human osteoclast formation. Endocrinology 146:5204-5214.
34. Keila S, Kelner A, Weinreb M 2001 Systemic prostaglandin E2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro. J Endocrinol 168:131-139.
35. Sakuma Y, Tanaka K, Suda M, Komatsu Y, Yasoda A, Miura M, Ozasa A, Narumiya S, Sugimoto Y, Ichikawa A, Ushikubi F, Nakao K 2000 Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype. Infect Immun 68:6819-6825.
36. Ohshiba T, Miyaura C, Ito A 2003 Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis. Biochem Biophys Res Commun 300:957-964.
37. Weinreb M, Suponitzky I, Keila S 1997 Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow. Bone 20:521-526.
38. Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Suda T 2000 The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: An analysis using specific agonists for the respective EPs. Endocrinology 141:1554-1559.
39. Sakuma Y, Tanaka K, Suda M, Yasoda A, Natsui K, Tanaka I, Ushikubi F, Narumiya S, Segi E, Sugimoto Y, Ichikawa A, Nakao K 2000 Crucial involvement of the EP4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines and lipopolysaccharide. J Bone Miner Res 15:218-227.
40. Gruber R, Karreth F, Fischer MB, Watzek G 2002 Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin/RANKL-dependent mechanism. Bone 30:726-732.